Healthcare provider profile · identity verified

Bradley Paul Carter, M.D.

Internal Medicine · KNOXVILLE, TN · NPI 1801845821

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	459	117
Atorvastatin Calcium	Atorvastatin Calcium	413	107
Albuterol Sulfate Hfa	Albuterol Sulfate	330	90
Gabapentin	Gabapentin	215	48
Pravastatin Sodium	Pravastatin Sodium	215	56
Pantoprazole Sodium	Pantoprazole Sodium	214	59
Lisinopril	Lisinopril	179	42
Venlafaxine Hcl Er	Venlafaxine Hcl	178	27
Furosemide	Furosemide	155	39
Famotidine	Famotidine	142	36
Metformin Hcl	Metformin Hcl	140	29
Omeprazole	Omeprazole	133	32
Levothyroxine Sodium	Levothyroxine Sodium	128	29
Trazodone Hcl	Trazodone Hcl	120	31
Tamsulosin Hcl	Tamsulosin Hcl	113	31
Fluticasone Propionate	Fluticasone Propionate	110	30
Metoprolol Tartrate	Metoprolol Tartrate	104	25
Hydralazine Hcl	Hydralazine Hcl	102	22
Ventolin Hfa	Albuterol Sulfate	102	25
Tizanidine Hcl	Tizanidine Hcl	99	27
Montelukast Sodium	Montelukast Sodium	78	17
Pregabalin	Pregabalin	78	14
Clopidogrel	Clopidogrel Bisulfate	74	19
Spiriva Handihaler	Tiotropium Bromide	73	19
Carvedilol	Carvedilol	71	20
Metoprolol Succinate	Metoprolol Succinate	68	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	12
Chlorthalidone	Chlorthalidone	64	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	21
Losartan Potassium	Losartan Potassium	63	15
Spironolactone	Spironolactone	61	12
Hydrochlorothiazide	Hydrochlorothiazide	58	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	57	15
Doxycycline Monohydrate	Doxycycline Monohydrate	57	49
Potassium Chloride	Potassium Chloride	57	17
Duloxetine Hcl	Duloxetine Hcl	55	16
Rosuvastatin Calcium	Rosuvastatin Calcium	54	12
Levetiracetam	Levetiracetam	53	11
Sertraline Hcl	Sertraline Hcl	53	15
Esomeprazole Magnesium	Esomeprazole Magnesium	52	suppressed
Allopurinol	Allopurinol	51	15
Diclofenac Sodium	Diclofenac Sodium	50	19
Clonidine Hcl	Clonidine Hcl	49	12
Metformin Hcl Er	Metformin Hcl	47	12
Xarelto	Rivaroxaban	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	12
Buspirone Hcl	Buspirone Hcl	42	suppressed
Valsartan	Valsartan	42	suppressed
Ozempic	Semaglutide	39	13
Jardiance	Empagliflozin	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Naproxen	Naproxen	35	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Eliquis	Apixaban	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Baclofen	Baclofen	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Ibandronate Sodium	Ibandronate Sodium	26	11
Nitroglycerin	Nitroglycerin	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Atenolol	Atenolol	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	12
Tramadol Hcl	Tramadol Hcl	24	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	23
Azelastine Hcl	Azelastine Hcl	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Linzess	Linaclotide	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Clotrimazole	Clotrimazole	22	11
Prednisone	Prednisone	22	15
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Colchicine	Colchicine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Aripiprazole	Aripiprazole	19	suppressed
Brilinta	Ticagrelor	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	19	suppressed
Trintellix	Vortioxetine Hydrobromide	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Tiotropium Bromide	Tiotropium Bromide	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fluconazole	Fluconazole	15	13
Meclizine Hcl	Meclizine Hcl	15	suppressed
Novolog	Insulin Aspart	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Rexulti	Brexpiprazole	14	suppressed
Veltassa	Patiromer Calcium Sorbitex	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Cefdinir	Cefdinir	13	11
Glipizide	Glipizide	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Topiramate	Topiramate	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error